Weekly shot helps people shed pounds in Year-Long study
NCT ID NCT06041217
First seen Jan 15, 2026 · Last updated Jun 17, 2026 · Updated 23 times
Summary
This study tested a weekly injection of semaglutide (2.4 mg) to help adults with overweight or obesity lose weight. About 242 people took part, comparing the drug to a placebo over roughly one year. The main goal was to see how much weight they lost and how many lost at least 5% of their body weight.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beijing Hospital
Beijing, Beijing Municipality, 100730, China
-
Changzhou No.2 People's Hospital, Yanghu Branch
Changzhou, Jiangsu, 213003, China
-
China Medical University Hospital
Taichung, 404, Taiwan
-
Chongqing University Three Gorges Hospital
Chongqing, Chongqing Municipality, 404000, China
-
Ditmanson Medical Foundation Chia-Yi Christian Hospital
Chiayi City, 600, Taiwan
-
Fujian Medical University Union Hospital-Endocrinology
Fuzhou, Fujian, 350001, China
-
Hengshui People's Hospital (Harrison International Peace Hospital)-Endocrinology
Hengshui, Hebei, 053000, China
-
Huizhou Central People's Hospital-Endocrinology
Huizhou, Guangdong, 516001, China
-
Jinan Central Hospital
Jinan, Shandong, 250013, China
-
National Cheng Kung University Hospital
Tainan, 704, Taiwan
-
National Taiwan University Hospital_main
Taipei, 100, Taiwan
-
Qinghai Provincial People's Hospital
Xining, Qinghai, 810007, China
-
Shanghai Fifth People's Hospital-Endocrinology
Shanghai, Shanghai Municipality, 200240, China
-
Shanghai Pudong New Area People's Hospital-Endocrinology
Shanghai, Shanghai Municipality, 201200, China
-
Shiyan Taihe Hospital (Affiliated Hospital of Hubei University of Medicine)-Endocrinology
Shiyan, Hubei, 442008, China
-
Taipei Medical University Hospital
Taipei, 110, Taiwan
-
The Affiliated Hospital of Jiangsu University-Endocrinology
Zhenjiang, Jiangsu, 212001, China
-
The First Bethune hospital of Jilin University-Endocrinology
Changchun, Jilin, 130061, China
-
The Second Affiliated Hospital of Nanjing Medical University-Endocrinology
Nanjing, Jiangsu, 210011, China
-
The Second Affiliated Hospital of Nanjing Medical University_Nanjing
Nanjing, Jiangsu, 210011, China
-
Tongren Hospital Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200336, China
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.